Events
Ahead of the 2026 World Tuberculosis (TB) Day on 24th March, the LIGHT Consortium partners in Kenya, the African Institute for Development Policy (AFIDEP) and the Respiratory Society of Kenya (ReSoK) in collaboration with Kenya’s Ministry of Health Division of Tuberculosis and Lung Health the National Tuberculosis, Leprosy and Lung Disease Program (NTLD-P) are hosting a Kenya National Stakeholders’ Dissemination Forum.
Date: Monday 16th March 2026
Time: 8.30am to 13.30pm
Venue: Radison Blu, Upper Hill Kenya
Through various panel discussions and engagements, the goal for this high-level event is to promote coordinated policy uptake and implementation of recommendations emerging from LIGHT research, Community Rights & Gender assessments, KAP and TB Stigma Index surveys, and Digital Chest X-ray impact report.
The research findings provide comprehensive evidence on gender, stigma, human rights, community systems, and behavioural determinants influencing TB outcomes in Kenya.
Speakers:
- Hon. Stephen Mule – Member of Parliament, TB Champion, and leader within the Global/Africa TB Caucus
- Prof Prof Jeremiah Chakaya – Respiratory Society of Kenya (ReSoK) LIGHT Consortium
- Prof Bertie Squire – Liverpool School of Tropical Medicine, LIGHT Consortium
- Dr Rachael Thomson – The CEO, LIGHT Consortium
- Ms Evaline Kibuchi – National Coordinator, STOP TB Partnership Kenya, Global TB Caucus
- Dr Salome Okutoyi – US State Department
- Dorcas Kiptui- Gender Lead, Division of Tuberculosis and other Lung Diseases
Session moderators:
- Dr Immaculate Kathure – Head of National TB Programme
- Nkirote Mugambi-Nyaboga (Centre for Health Solutions-Kenya – CHS)
- Dr Samson Muga – (CHS)
- Rhoda Pola (ReSoK)
The objectives of the event are:
i. To disseminate key research findings and generate dialogue on their implications for strengthening national tuberculosis policies, strategies, and implementation frameworks in Kenya.
ii. To synthesise cross-study evidence and inform priority policy and programmatic actions to address gaps across the TB prevention, diagnosis, treatment, and care cascade.
iii. Enhance collaboration between government, civil society, researchers, and communities, and secure stakeholder commitments for implementation.
iv. To integrate lived experiences of TB champions, adolescents and young people, and health workers into policy dialogue.
The Leaving no one behInd; transforming Gendered Pathways to Health for TB (LIGHT) consortium, a six-year cross-disciplinary global health research programme, funded by UK aid.
LIGHT aims to support policy and practice in transforming gendered pathways to health for people affected by TB in urban settings – enhancing health and well-being, improving socio-economic outcomes and equity, and contributing to the efforts of ending TB by 2030.
Learn more about LIGHT Consortium here: https://bit.ly/42cSbKo

